(512) 444-1414|info@yourdomain.com

Dr. Shahryar Kavoussi

AFRM along with UofSC publish an article on the expression of pregnancy-associated plasma protein of pregnancy-A (PAPP-A) in blastocoel fluid-cultured medium (BFCM).

Pregnancy-associated plasma protein of pregnancy-A (PAPP-A), a marker that is clinically used as part of prenatal testing by measurement in maternal serum during the first trimester of pregnancy, has been shown to predict adverse maternal and fetal obstetric outcomes such as pre-eclampsia and intrauterine growth restriction among others.  “Our study is the first to […]

AFRM’s medical and laboratory team co-author the original research article, “The effects of hysteroscopic morcellation of endometrial polyps on frozen embryo transfer outcomes”, in collaboration with the Institute for Social Research at University of Michigan, in the journal European Journal of Obstetrics & Gynecology and Reproductive Biology.

“Our article specifically looked at whether or not hysteroscopic removal of endometrial polyps by means of a technique known as morcellation affected subsequent first frozen embryo transfer outcomes when compared with those who did not have endometrial polyps and had first frozen embryo transfers.  There were no differences in implantation rates, clinical pregnancy rates, […]

AFRM and UofSC collaboratively present two research projects at the ASRM meeting

The medical and embryology teams at Austin Fertility & Reproductive Medicine/Westlake IVF, in a collaborative study with the Department of Biomedical Sciences at The University of South Carolina Greenville, presented two research projects at the 76th annual American Society for Reproductive Medicine (ASRM) meeting in Baltimore on October 19th, 2021.

Blastocyst fluid-conditioned media (BFCM) is […]

Reassuring studies reveal COVID 19 vaccination does not have an adverse impact on female or male fertility

Although the mechanism of action of the Pfizer and Moderna COVID 19 mRNA vaccines did not raise a scientific concern for an impact on fertility, reassuring studies have been published that prove there is not a significant concern.  Dr. Shahryar Kavoussi and Dr. Parviz Kavoussi discussed the data in these scientific publications on Fox […]

Dr. Shahryar Kavoussi and patients Karin and William Baker are interviewed on KEYE CBS News on Mother’s Day about embryo transfer during Austin’s recent ice storm

During the recent ice storm in the Austin area in mid-February of this year, an Austin couple was able to have their embryo transfer at Westlake IVF.  “It took ultimate teamwork to be able to perform IVF procedures for our patients during the ice storm”, said Dr. Shahryar Kavoussi.  “We needed to have one […]

Dr. Shahryar Kavoussi is interviewed on KEYE CBS News about COVID-19 vaccines and fertility

Do COVID-19 vaccines adversely affect fertility?  In December 2020, there was misinformation via a post on social media, which falsely claimed that COVID-19 vaccines negatively impact fertility.  The theory, which has been shown to be untrue, was that the antibodies generated by the COVID-19 vaccination would not only defend the body against the spike […]

Patient Safety Awareness Week (March 14 – 20th, 2021)

March 14 – 20th this year is Patient Safety Awareness Week. We believe that safe patient outcome is of utmost importance. For patients who are seeking infertility treatment, here is a short list of what to look for to ensure you are getting care that puts safety first:

1)  Work with a fertility specialist with […]

Dr. Shahryar Kavoussi is interviewed on KVUE ABC News about COVID-19 vaccines and pregnancy

Available data suggest that symptomatic pregnant patients with COVID-19 are at increased risk of more severe illness compared with nonpregnant women.  The absolute risk for severe COVID-19 among pregnant women is low; however, data indicates an increased risk of ICU admission, need for mechanical ventilation and ventilatory support, and death reported in pregnant women […]

AFRM team publishes study converting men maintaining fertility from clomid to Natesto.

As more men are waiting until later in life to father children, and more men are being diagnosed with low testosterone at a younger age, there is a fair amount of cross-over in these 2 groups of men.  A longstanding challenge in reproductive medicine has been treating men with low testosterone in a fertility […]

Dr. Shahryar Kavoussi publishes report on elagolix use to treat a uterine adenomyoma

Elagolix (Orilissa®) is the first orally-available medication in a class of medications known as gonadotropin releasing hormone (GnRH) antagonists.  This medication has been approved by the United States Food and Drug Administration for the treatment of moderate to severe pelvic pain due to endometriosis.  In this case report, elagolix was used to treat a […]